NCT03812549 2025-03-04Safety and Tolerability Evaluation of Sintilimab in Combination With Radiation in Stage IV NSCLC PatientsSichuan UniversityPhase 1 Completed29 enrolled 11 charts
NCT03568539 2021-06-01IBI308 in Subjects With Advanced/Metastatic Solid MalignanciesInnovent Biologics (Suzhou) Co. Ltd.Phase 1 Completed39 enrolled 16 charts